Capital raising by cannabis companies is down 64% to $4 billion to date in 2022 as compared with 2021, Viridian Capital Advisors reported Wednesday. Total equity issuance has fallen 74.4% to about $1 billion, with total debt issuance down 48.2% to about $2 billion. Public companies have accounted for 74.5% of total financing in 2022, down from 79.8% in 2021. The AdvisorShares Pure U.S. Cannabis ETF
MSOS,
is down 52% in 2022, and the ETFMG Alternative Harvest ETF
MJ,
has fallen 47.7%.
